News Headlines Article

The Debate Is Heated on a Drug for Diabetes
New York Times

Government experts and a panel of medical advisers repeatedly voiced skepticism on Tuesday about the trustworthiness of GlaxoSmithKline, which makes the controversial diabetes drug Avandia. The committee is to vote Wednesday to advise the Food and Drug Administration on whether the drug, Avandia, which is widely used despite persistent concerns about its safety, should remain on the market.